Inflammatory and Metabolic Blood Parameters Associated with Aggression, Impulsivity, and Suicide Risk Among Male Patients with Antisocial Personality Disorder in a Forensic Psychiatry Unit in Turkey: A Cross-Sectional Comparative Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Ethics Committee Approval
2.2. Criteria for Inclusion and Exclusion
2.3. Data Collection Tools
2.4. Laboratory Samples
2.5. Statistical Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Association, A.P. Diagnostic and Statistical Manual of Mental Disorders; American Psychiatric Association: Washington, DC, USA, 2013. [Google Scholar]
- Fazel, S.; Danesh, J. Serious mental disorder in 23 000 prisoners: A systematic review of 62 surveys. Lancet 2002, 359, 545–550. [Google Scholar] [CrossRef]
- Black, D.W.; Baumgard, C.H.; Bell, S.E. Death rates in 71 men with antisocial personality disorder: A comparison with general population mortality. Psychosomatics 1996, 37, 131–136. [Google Scholar] [CrossRef] [PubMed]
- Moffitt, T.E. Genetic and environmental influences on antisocial behaviors: Evidence from behavioral–genetic research. Adv. Genet. 2005, 55, 41–104. [Google Scholar] [PubMed]
- Alcorn, J.L., III; Gowin, J.L.; Green, C.E.; Swann, A.C.; Moeller, F.G.; Lane, S.D. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J. Neuropsychiatry Clin. Neurosci. 2013, 25, 229–232. [Google Scholar] [CrossRef] [PubMed]
- Ammerman, B.A.; Kleiman, E.M.; Uyeji, L.L.; Knorr, A.C.; McCloskey, M.S. Suicidal and violent behavior: The role of anger, emotion dysregulation, and impulsivity. Personal. Individ. Differ. 2015, 79, 57–62. [Google Scholar] [CrossRef]
- Salvagno, G.L.; Sanchis-Gomar, F.; Picanza, A.; Lippi, G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit. Rev. Clin. Lab. Sci. 2015, 52, 86–105. [Google Scholar] [CrossRef]
- Dowlati, Y.; Herrmann, N.; Swardfager, W.; Liu, H.; Sham, L.; Reim, E.K.; Lanctôt, K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67, 446–457. [Google Scholar] [CrossRef]
- Miller, A.H.; Raison, C.L. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 2016, 16, 22–34. [Google Scholar] [CrossRef]
- Karageorgiou, V.; Milas, G.P.; Michopoulos, I. Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis. Schizophr. Res. 2019, 206, 4–12. [Google Scholar] [CrossRef]
- Gokcay, H.; Takim, U.; Acikgoz, M.G.; Namli, M.N.; Balcioglu, Y.H. Exploring the role of impulsivity, aggression, lipid profiles, and inflammatory markers in suicide attempts: A cross-diagnostic study. Braz. J. Psychiatry 2025, 47, e20244026. [Google Scholar]
- Felger, J.C.; Lotrich, F.E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience 2013, 246, 199–229. [Google Scholar] [CrossRef] [PubMed]
- Hutto, B.R. Folate and cobalamin in psychiatric illness. Compr. Psychiatry 1997, 38, 305–314. [Google Scholar] [CrossRef] [PubMed]
- Don, B.R.; Kaysen, G. Poor nutritional status and inflammation: Serum albumin: Relationship to inflammation and nutrition. Semin. Dial. 2004, 17, 432–437. [Google Scholar] [CrossRef]
- González-Castro, T.B.; Genis-Mendoza, A.D.; León-Escalante, D.I.; Hernández-Díaz, Y.; Juárez-Rojop, I.E.; Tovilla-Zárate, C.A.; López-Narváez, M.L.; Marín-Medina, A.; Nicolini, H.; Castillo-Avila, R.G. Possible association of cholesterol as a biomarker in suicide behavior. Biomedicines 2021, 9, 1559. [Google Scholar] [CrossRef] [PubMed]
- Coccaro, E.F.; Lee, R.; Coussons-Read, M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 2014, 71, 158–165. [Google Scholar] [CrossRef]
- Rosenblat, J.D.; Brietzke, E.; Mansur, R.B.; Maruschak, N.A.; Lee, Y.; McIntyre, R.S. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications. J. Affect. Disord. 2015, 188, 149–159. [Google Scholar] [CrossRef]
- Buss, A.H.; Perry, M. The aggression questionnaire. J. Personal. Soc. Psychol. 1992, 63, 452. [Google Scholar] [CrossRef]
- Andaç Demırtaş Madran, H. The reliability and validity of the Buss-Perry Aggression Questionnaire (BAQ)-Turkish version. Turk Psikiyatr. Derg. 2013, 24, 124. [Google Scholar]
- Güleç, H.; Tamam, L.; Turhan, M.; Karakuş, G.; Zengin, M.; Stanford, M.S. Psychometric Properties of the Turkish Version of the Barratt Impulsiveness Scale-11. Klin. Psikofarmakol. Bul. 2008, 18, 251–258. [Google Scholar]
- Cull, J.G.; Gill, W.S. Suicide probability scale. In Suicide Probability Scale; Western Psychological Services: Los Angeles, CA, USA, 1988. [Google Scholar] [CrossRef]
- Atlı, Z.; Eskin, M.; Dereboy, Ç. The validity and the reliliability of Suicide Probability Scale (SPS) in clinical sample. Turk. J. Clin. Psychiatry 2009, 12, 111–124. [Google Scholar]
- Coid, J.; Yang, M.; Ullrich, S.; Roberts, A.; Moran, P.; Bebbington, P.; Brugha, T.; Jenkins, R.; Farrell, M.; Lewis, G. Psychopathy among prisoners in England and Wales. Int. J. Law Psychiatry 2009, 32, 134–141. [Google Scholar] [CrossRef]
- Paris, J. Nature and Nurture in Personality and Psychopathology: A Guide for Clinicians; Routledge: London, UK, 2022. [Google Scholar]
- Fridell, M.; Hesse, M.; Jæger, M.M.; Kühlhorn, E. Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: Relation to type of substance and type of crime. Addict. Behav. 2008, 33, 799–811. [Google Scholar] [CrossRef] [PubMed]
- Seid, M.; Anbesaw, T.; Melke, S.; Beteshe, D.; Mussa, H.; Asmamaw, A.; Shegaw, M. Antisocial personality disorder and associated factors among incarcerated in prison in Dessie city correctional center, Dessie, Ethiopia: A cross-sectional study. BMC Psychiatry 2022, 22, 53. [Google Scholar] [CrossRef] [PubMed]
- Hsu, M.C.; Tu, C.H. Adult patients with schizophrenia using violence towards their parents: A phenomenological study of views and experiences of violence in parent–child dyads. J. Adv. Nurs. 2014, 70, 336–349. [Google Scholar] [CrossRef] [PubMed]
- Puiu, A.A.; Wudarczyk, O.; Goerlich, K.S.; Votinov, M.; Herpertz-Dahlmann, B.; Turetsky, B.; Konrad, K. Impulsive aggression and response inhibition in attention-deficit/hyperactivity disorder and disruptive behavioral disorders: Findings from a systematic review. Neurosci. Biobehav. Rev. 2018, 90, 231–246. [Google Scholar] [CrossRef]
- Seo, D.; Patrick, C.J.; Kennealy, P.J. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress. Violent Behav. 2008, 13, 383–395. [Google Scholar] [CrossRef]
- Durmaz, O. The relationship between harming behavior and substance use profile, and attention deficit hyperactivity disorder symptoms in antisocial personality disorder. Dusunen Adam J. Psychiatry Neurol. Sci. 2017, 30, 194. [Google Scholar] [CrossRef]
- Sabanciogullari, S.; Avci, D.; Dogan, S.; Kelleci, M.; Ata, E. Suicide probability and affecting factors in psychiatric inpatients/Psikiyatri kliniginde yatan hastalarda intihar olasiligi ve etkileyen etkenler. Anadolu Psikiyatr. Derg. 2015, 16, 164–173. [Google Scholar] [CrossRef]
- Jain, R.; George, A.; Narnoli, S. Haematological changes in alcohol and substance use disorders—An overview. Int. Arch. Subst. Abuse Rehabil. 2020, 2, 006. [Google Scholar] [CrossRef]
- Apple, C.G.; Miller, E.S.; Kannan, K.B.; Thompson, C.; Darden, D.B.; Efron, P.A.; Mohr, A.M. Prolonged chronic stress and persistent iron dysregulation prevent anemia recovery following trauma. J. Surg. Res. 2021, 267, 320–327. [Google Scholar] [CrossRef]
- Peng, Y.-F.; Xiang, Y.; Wei, Y.-S. The significance of routine biochemical markers in patients with major depressive disorder. Sci. Rep. 2016, 6, 34402. [Google Scholar] [CrossRef] [PubMed]
- Yin, X.Y.; Cai, Y.; Zhu, Z.H.; Zhai, C.P.; Li, J.; Ji, C.F.; Chen, P.; Wang, J.; Wu, Y.M.; Chan, R.C. Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia. Front. Psychiatry 2022, 13, 957671. [Google Scholar] [CrossRef] [PubMed]
- Albert, U.; De Cori, D.; Aguglia, A.; Barbaro, F.; Bogetto, F.; Maina, G. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J. Affect. Disord. 2015, 173, 170–175. [Google Scholar] [CrossRef]
- Black, C.N.; Bot, M.; Scheffer, P.G.; Snieder, H.; Penninx, B.W. Uric acid in major depressive and anxiety disorders. J. Affect. Disord. 2018, 225, 684–690. [Google Scholar] [CrossRef]
- Gherghina, M.-E.; Peride, I.; Tiglis, M.; Neagu, T.P.; Niculae, A.; Checherita, I.A. Uric acid and oxidative stress—Relationship with cardiovascular, metabolic, and renal impairment. Int. J. Mol. Sci. 2022, 23, 3188. [Google Scholar] [CrossRef] [PubMed]
- Yıldız, S.; Kazğan, A.; Kurt, O.; Korkmaz, S.; Uğur, K. The correlation between serum uric acid level and certain clinical variables in antisocial personality disorder patients. Neuropsychiatr. Investig. 2021, 59, 45–52. [Google Scholar] [CrossRef]
- Troisi, A.; D’Argenio, A. Apolipoprotein AI/apolipoprotein B ratio and aggression in violent and nonviolent young adult males. J. Psychiatr. Res. 2006, 40, 466–472. [Google Scholar] [CrossRef]
- Suneson, K.; Asp, M.; Träskman-Bendz, L.; Westrin, Å.; Ambrus, L.; Lindqvist, D. Low total cholesterol and low-density lipoprotein associated with aggression and hostility in recent suicide attempters. Psychiatry Res. 2019, 273, 430–434. [Google Scholar] [CrossRef]
- Bella, E.; Kafetzopoulos, V.; Chatzittofis, A. Sex differences of the lipid profile, impulsivity and suicidality in psychiatric inpatients. Front. Psychiatry 2025, 16, 1595783. [Google Scholar] [CrossRef]
- Fan, T.; Luo, X.; Li, X.; Shen, Y.; Zhou, J. The association between depression, anxiety, and thyroid disease: A UK Biobank prospective cohort study. Depress. Anxiety 2024, 2024, 8000359. [Google Scholar] [CrossRef]
- İnaltekin, A.; Yağcı, İ. Evaluation of simple markers of inflammation and systemic immune inflammation index in schizophrenia, bipolar disorder patients and healthy controls. Turk. J. Psychiatry 2021, 34, 11. [Google Scholar] [CrossRef] [PubMed]
- Tunç, E.B.; Çelik, H.E.A.; Kendirlioğlu, B.K.; Kaymakçı, E.Ç.; Çiftçi, H.B.; Demir, Ş.; Küçükgöncü, S. Aggregate Index of Systemic Inflammation and Systemic Inflammatory Response Index: Could be Potential Biomarkers to Monitor Bipolar Disorder Patients? An Observational Study. Med. J. Bakirkoy 2025, 21, 207–214. [Google Scholar] [CrossRef]
- Taşçi, G.; Şüheda, K.; Korkmaz, S.; Atmaca, M. Peripheral inflammatory parameters in patients with antisocial personality disorder. Arch. Neuropsychiatry 2021, 59, 38. [Google Scholar]
- Wang, T.-Y.; Lee, S.-Y.; Hu, M.-C.; Chen, S.-L.; Chang, Y.-H.; Chu, C.-H.; Lin, S.-H.; Li, C.-L.; Wang, L.-J.; Chen, P.S. More inflammation but less brain-derived neurotrophic factor in antisocial personality disorder. Psychoneuroendocrinology 2017, 85, 42–48. [Google Scholar] [CrossRef]
- Balcioglu, Y.H.; Balcioglu, S.S.K.; Oncu, F.; Turkcan, A.; Yorulmaz, A.C. Impulsive and aggressive traits and increased peripheral inflammatory status as psychobiological substrates of homicide behavior in schizophrenia. Eur. J. Psychiatry 2022, 36, 207–214. [Google Scholar] [CrossRef]
- Baldini, V.; Gnazzo, M.; Varallo, G.; Atti, A.R.; De Ronchi, D.; Fiorillo, A.; Plazzi, G. Inflammatory markers and suicidal behavior: A comprehensive review of emerging evidence. Ann. Gen. Psychiatry 2025, 24, 36. [Google Scholar] [CrossRef]
- Yeşilkaya, Ü.H.; Şen, M.; Balcıoğlu, Y.H.; Gökçay, H.; Çelikkıran, P.; Balcıoğlu, S.K.; Karamustafalıoğlu, N. Evaluation of the correlation between peripheral inflammatory markers and suicide risk in drug-naive first-episode schizophrenia. Arch. Neuropsychiatry 2024, 61, 275. [Google Scholar] [CrossRef]
- Tatayeva, R.; Tussupova, A.; Koygeldinova, S.; Serkali, S.; Suleimenova, A.; Askar, B. The Level of Serotonin and the Parameters of Lipid Metabolism Are Dependent on the Mental Status of Patients with Suicide Attempts. Psychiatry Int. 2024, 5, 773–792. [Google Scholar] [CrossRef]
| Total (n = 113) | Control (n = 56) | Patient (n = 57) | p | |
|---|---|---|---|---|
| Gender | ||||
| Female, n (%) | ||||
| Male, n (%) | 113 (100) | 56 (100) | 57 (100) | |
| Age, median (min–max) | 33 (18–54) | 33 (20–54) | 33 (18–47) | 0.908 |
| Marital status | <0.001 | |||
| Single or widowed, n (%) | 59 (52.2) | 19 (33.9) | 40 (70.2) | |
| Married, n (%) | 54 (47.8) | 37 (66.1) | 17 (29.8) | |
| Level of education | <0.001 | |||
| Primary school, n (%) | 18 (15.9) | 0 (0) * | 18 (31.6) * | |
| Secondary school, n (%) | 23 (20.4) | 7 (12.5) * | 16 (28.1) * | |
| High school, n (%) | 40 (35.4) | 19 (33.9) | 21 (36.8) | |
| University, n (%) | 32 (28.3) | 30 (53.6) * | 2 (3.5) * | |
| Alcohol use | <0.001 | |||
| No, n (%) | 88 (77.9) | 56 (100) | 32 (56.1) | |
| Yes, n (%) | 25 (22.1) | 0 (0) | 25 (43.9) | |
| Substance use | <0.001 | |||
| No, n (%) | 82 (72.6) | 56 (100) | 26 (45.6) | |
| Yes, n (%) | 31 (27.4) | 0 (0) | 31 (54.4) | |
| Legal problems due to alcohol/substance use | <0.001 | |||
| No, n (%) | 82 (72.6) | 56 (100) | 26 (45.6) | |
| Yes, n (%) | 31 (27.4) | 0 (0) | 31 (54.4) | |
| Imprisonment due to alcohol/substance abuse | <0.001 | |||
| No, n (%) | 88 (77.9) | 56 (100) | 32 (56.1) | |
| Yes, n (%) | 25 (22.1) | 0 (0) | 25 (43.9) | |
| Previous Inpatient Treatment | <0.001 | |||
| No, n (%) | 81 (71.7) | 56 (100) | 25 (43.9) | |
| Yes, n(%) | 32 (28.3) | 0 (0) | 32 (56.1) | |
| Addiction Treatment Center (ATC) hospitalization | <0.001 | |||
| No, n (%) | 97 (85.8) | 56 (100) | 41 (71.9) | |
| Yes, n (%) | 16 (14.2) | 0 (0) | 16 (28.1) | |
| Additional medical illness | <0.001 | |||
| No, n (%) | 98 (86.7) | 56 (100) | 42 (73.7) | |
| Yes, n (%) | 15 (13.3) | 0 (0) | 15 (26.3) | |
| Alcohol and substance abuse in the family | <0.001 | |||
| No, n (%) | 101 (89.4) | 56 (100) | 45 (78.9) | |
| Yes, n (%) | 12 (10.6) | 0 (0) | 12 (21.1) | |
| Signs of self-harm | <0.001 | |||
| No, n (%) | 67 (59.3) | 56 (100) | 11 (19.3) | |
| Yes, n (%) | 46 (40.7) | 0 (0) | 46 (80.7) | |
| Suicide attempt | <0.001 | |||
| No, n (%) | 79 (69.9) | 56 (100) | 23 (40.4) | |
| Yes, n (%) | 34 (30.1) | 0 (0) | 34 (59.6) | |
| Tattoo | <0.001 | |||
| No, n (%) | 76 (67.3) | 56 (100) | 20 (35.1) | |
| Yes, n (%) | 37 (32.7) | 0 (0) | 37 (64.9) |
| Total (n = 113) | Control (n = 56) | Patient (n = 57) | p | |
|---|---|---|---|---|
| The Barratt Impulsiveness Scale-11 | ||||
| Attentional score, median (min–max) | 26 (9–41) | 31 (14–41) | 19 (9–30) | <0.001 |
| Motor score, median (min–max) | 15 (7–40) | 12 (7–17) | 25 (10–40) | <0.001 |
| Non-planning, median (min–max) | 22 (8–44) | 20 (8–26) | 31 (14–44) | <0.001 |
| Total score, median (min–max) | 66 (29–108) | 63 (29–78) | 74 (39–108) | <0.001 |
| The Buss–Perry Aggression Questionnaire | ||||
| Physical aggression, median (min–max) | 9 (0–45) | 3 (0–6) | 25 (9–45) | <0.001 |
| Verbal aggression, median (min–max) | 6 (1–29) | 3 (1–6) | 17 (6–29) | <0.001 |
| Anger, median (min–max) | 8 (0–35) | 3 (0–8) | 22 (7–35) | <0.001 |
| Hostility, median (min–max) | 9 (0–40) | 2 (0–5) | 24 (9–40) | <0.001 |
| Total score, median (min–max) | 39 (3–141) | 12 (3–22) | 86 (39–141) | <0.001 |
| Suicide Probability Scale | ||||
| Hopelessness, median (min–max) | 19 (11–41) | 15 (11–19) | 30 (18–41) | <0.001 |
| Suicide ideation, median (min–max) | 12 (9–28) | 9 (9–13) | 21 (11–28) | <0.001 |
| Negative self-evaluation, median (min–max) | 19 (9–48) | 17 (15–20) | 22 (9–48) | <0.001 |
| Hostility, median (min–max) | 9 (7–26) | 8 (7–9) | 15 (7–26) | <0.001 |
| Total score, median (min–max) | 56 (45–119) | 49 (45–56) | 91 (54–119) | <0.001 |
| The Barratt Impulsiveness Scale-11 | The Buss–Perry Aggression Questionnaire | Suicide Probability Scale | ||||
|---|---|---|---|---|---|---|
| r | p | r | p | r | p | |
| Age | −0.004 | 0.976 | 0.014 | 0.918 | 0.070 | 0.606 |
| Height | 0.117 | 0.388 | 0.222 | 0.097 | 0.206 | 0.124 |
| Weight | 0.024 | 0.860 | 0.096 | 0.479 | 0.208 | 0.121 |
| WBC | −0.059 | 0.664 | −0.003 | 0.983 | −0.113 | 0.401 |
| RBC | 0.064 | 0.638 | 0.126 | 0.352 | −0.024 | 0.862 |
| HB | −0.041 | 0.765 | 0.149 | 0.269 | 0.065 | 0.631 |
| PLT | −0.035 | 0.798 | −0.115 | 0.394 | −0.134 | 0.319 |
| Neutrophil | 0.022 | 0.868 | 0.062 | 0.645 | −0.019 | 0.891 |
| Lymphocyte | −0.134 | 0.321 | −0.115 | 0.395 | −0.206 | 0.125 |
| Monocyte | −0.126 | 0.350 | 0.018 | 0.894 | −0.110 | 0.417 |
| Eosinophil | −0.221 | 0.099 | −0.095 | 0.483 | −0.247 | 0.064 |
| Basophil | 0.272 | 0.041 | 0.024 | 0.859 | 0.235 | 0.078 |
| Glucose | 0.034 | 0.803 | 0.038 | 0.778 | −0.048 | 0.723 |
| Urea | −0.175 | 0.193 | −0.188 | 0.162 | −0.111 | 0.410 |
| Creatinine | −0.139 | 0.302 | 0.089 | 0.512 | −0.139 | 0.303 |
| Uric acid | −0.163 | 0.227 | −0.167 | 0.214 | 0.002 | 0.986 |
| Total protein | 0.107 | 0.429 | 0.215 | 0.109 | 0.124 | 0.360 |
| Albumin | 0.213 | 0.111 | 0.220 | 0.101 | 0.130 | 0.335 |
| AST | −0.238 | 0.074 | −0.071 | 0.602 | −0.023 | 0.867 |
| ALT | −0.042 | 0.758 | 0.039 | 0.772 | 0.279 | 0.036 |
| Cholesterol | −0.198 | 0.139 | −0.105 | 0.437 | 0.040 | 0.765 |
| HDL | −0.141 | 0.296 | 0.134 | 0.319 | −0.162 | 0.229 |
| LDL | −0.091 | 0.501 | −0.117 | 0.388 | 0.136 | 0.313 |
| Triglycerides | −0.055 | 0.683 | −0.026 | 0.847 | 0.002 | 0.985 |
| Na | −0.096 | 0.478 | −0.010 | 0.942 | 0.013 | 0.924 |
| K | −0.258 | 0.052 | −0.102 | 0.451 | −0.096 | 0.476 |
| TSH | 0.204 | 0.128 | 0.022 | 0.870 | 0.222 | 0.097 |
| T3 | −0.160 | 0.233 | 0.009 | 0.948 | −0.017 | 0.903 |
| T4 | −0.120 | 0.374 | 0.065 | 0.631 | 0.009 | 0.949 |
| B12 | 0.103 | 0.444 | 0.045 | 0.739 | 0.116 | 0.392 |
| CRP | −0.149 | 0.268 | −0.101 | 0.456 | −0.087 | 0.518 |
| CAR | −0.178 | 0.186 | −0.135 | 0.315 | −0.119 | 0.380 |
| NAR | −0.023 | 0.865 | −0.012 | 0.926 | −0.023 | 0.864 |
| NLR | 0.129 | 0.341 | 0.108 | 0.423 | 0.136 | 0.311 |
| MLR | −0.059 | 0.665 | −0.012 | 0.928 | 0.031 | 0.821 |
| PLR | 0.119 | 0.380 | 0.046 | 0.736 | 0.116 | 0.392 |
| SII | 0.115 | 0.396 | 0.076 | 0.574 | 0.098 | 0.470 |
| Total (n = 113) | Control (n = 56) | Patient (n = 57) | p | |
|---|---|---|---|---|
| WBC ± SD | 7.92 ± 1.99 | 7.81 ± 1.70 | 8.03 ± 2.25 | 0.555 |
| RBC ± SD | 5.23 ± 0.43 | 5.37 ± 0.34 | 5.09 ± 0.47 | <0.001 |
| Hb, median (min–max) | 15.7 (10.2–17.8) | 15.9 (13.4–17.4) | 15.4 (10.2–17.8) | 0.082 |
| HCT ± SD | 4.4 ± 2.9 | 45.8 ± 2 | 45.1 ± 3.5 | 0.189 |
| MCV, median (min–max) | 87.7 (60.4–103.1) | 85.2 (77.3–90.6) | 89.2 (60.4–103.1) | <0.001 |
| PLT ± SD | 250,550 ± 68,140 | 255,180 ± 64,518 | 246,000 ± 71,800 | 0.477 |
| MPV ± SD | 8.5 ± 0.9 | 8.5 ± 1.1 | 8.4 ± 0.9 | 0.704 |
| Neutrophil, median (min–max) | 4700 (1850–10,680) | 4730 (2470–9020) | 4700 (1850–10,680) | 0.323 |
| Lymphocyte, median (min–max) | 2240 (260–4560) | 2330 (990–4560) | 2030 (260–3830) | 0.065 |
| Monocyte, median (min–max) | 580 (200–1570) | 580 (340–1570) | 600 (200–1000) | 0.836 |
| Eosinophil, median (min–max) | 140 (0–500) | 150 (0–420) | 120 (0–500) | 0.143 |
| Basophil, median (min–max) | 40 (0–520) | 40 (0–90) | 5 (0–520) | 0.143 |
| RDW, median (min–max) | 41.1 (34.7–54.3) | 39.4 (34.7–48.1) | 42.7 (35.4–54.3) | <0.001 |
| Glucose, median (min–max) | 86 (54–189) | 89 (54–110) | 81 (56–189) | <0.001 |
| Urea, median (min–max) | 26.4 (12–70) | 29.5 (19–70) | 25 (12–49) | <0.001 |
| Creatinine ± SD | 0.82 ± 0.12 | 0.83 ± 0.13 | 0.82 ± 0.12 | 0.650 |
| Uric acid, median (min–max) | 4.98 (0.81–8.58) | 3.95 (0.81–7.86) | 5.11 (3–8.58) | 0.019 |
| Total protein, median (min–max) | 73 (55–82) | 75 (67–80) | 69 (55–82) | <0.001 |
| Albumin, median (min–max) | 44 (31–54) | 46 (31–50) | 43 (34–54) | <0.001 |
| AST, median (min–max) | 21 (12–84) | 22 (13.7–84) | 20 (12–49) | 0.257 |
| ALT, median (min–max) | 21(7–121) | 25 (7–121) | 17 (8–61) | 0.001 |
| Cholesterol, median (min–max) | 167 (98–343) | 176 (105–307) | 156 (98–343) | 0.086 |
| HDL, median (min–max) | 41 (23–89) | 45 (28–67) | 40 (23–89) | 0.013 |
| LDL, median (min–max) | 98 (38–257) | 102 (58–209) | 91 (38–257) | 0.132 |
| Triglycerides, median (min–max) | 119 (11–386) | 118 (50–386) | 119 (11–345) | 0.667 |
| Na, median (min–max) | 140 (133–147) | 139 (135–147) | 140 (133–144) | 0.991 |
| K ± SD | 4.29 ± 0.29 | 4.34 ± 0.25 | 4.24 ± 0.31 | 0.062 |
| TSH, median (min–max) | 1.52 (0.28–4.07) | 1.58 (0.28–3.12) | 1.33 (0.28–4.07) | 0.394 |
| T3 ± SD | 3.45 ± 0.4 | 3.42 ± 0.35 | 3.47 ± 0.45 | 0.530 |
| T4 ± SD | 0.87 ± 0.15 | 0.9 ± 0.14 | 0.84 ± 0.15 | 0.061 |
| B12, median (min–max) | 138 (50–639) | 238 (101–402) | 104 (50–639) | <0.001 |
| CRP, median (min–max) | 2.72 (0.96–29.3) | 2.41 (0.96–5.45) | 2.81 (1–29.3) | 0.031 |
| CAR, median (min–max) | 0.06 (0.02–0.76) | 0.05 (0.02–0.14) | 0.07 (0.02–0.76) | 0.005 |
| NAR, median (min–max) | 0.11 (0.04–0.28) | 0.10 (0.05–0.23) | 0.11 (0.04–0.28) | 0.058 |
| NLR, median (min–max) | 2.13 (0.65–9.44) | 1.87 (0.68–7.1) | 2.42 (0.65–9.44) | 0.019 |
| MLR, median (min–max) | 0.25 (0.14–3.42) | 0.25 (0.16–1.01) | 0.26 (0.14–3.42) | 0.407 |
| PLR, median (min–max) | 116.7 (51.9–446.2) | 107.7 (53.7–335.4) | 123.8 (51.9–446.2) | 0.118 |
| SII, median (min–max) | 491.4 (96.6–2771.8) | 466.7 (145.4–2360.9) | 538.4 (96.6–2771.8) | 0.118 |
| Using and/or Selling Substance (n = 10) | Murder (n = 5) | Theft (n = 11) | Involvement in Multiple Crimes (n = 18) | Other Crime (Sexual Abuse, Property Damage, Escape) (n = 13) | p | |
|---|---|---|---|---|---|---|
| The Barratt Impulsiveness Scale-11, median (min–max) | 70 (41–98) | 70 (61–90) | 75 (53–108) | 73 (43–99) | 75 (39–100) | 0.974 |
| The Buss–Perry Aggression Questionnaire, median (min–max) | 81 (39–134) | 88 (65–130) | 106 (51–138) | 82 (45–131) | 86 (41–141) | 0.244 |
| Suicide Probability Scale, median (min–max) | 80 (56–112) | 94 (79–113) | 92 (72–107) | 91 (54–119) | 91 (60–111) | 0.662 |
| CRP, median (min–max) | 2.81 (1–13.8) | 5.34 (2.25–17.6) | 2.25 (1.48–28) | 2.83 (1.24–29.3) | 3.49 (1–11.2) | 0.499 |
| CAR, median (min–max) | 0.07 (0.02–0.32) | 0.13 (0.05–0.46) | 0.05 (0.04–0.76) | 0.06 (0.03–0.64) | 0.08 (0.02–0.32) | 0.534 |
| NAR, median (min–max) | 0.1 (0.05–0.21) | 0.09 (0.05–0.28) | 0.11 (0.06–0.2) | 0.11 (0.04–0.2) | 0.08 (0.02–0.32) | 0.250 |
| NLR, median (min–max) | 2.19 (0.65–4.83) | 2.42 (2–8.35) | 1.89 (0.96–8.5) | 2.36 (0.73–9.44) | 2.47 (1.3–8.83) | 0.587 |
| MLR, median (min–max) | 0.25 (0.16–0.56) | 0.29 (0.2–3.42) | 0.23 (0.14–0.88) | 0.30 (0.18–0.71) | 0.27 (0.17–1) | 0.639 |
| PLR, median (min–max) | 110.1 (51.9–185.4) | 134.3 (114.7–446.2) | 116.7 (61.7–322.3) | 114.7 (62.7–276.8) | 150.8 (63.3–370) | 0.623 |
| SII, median (min–max) | 544 (96.6–1541.8) | 550 (402.9–1224.5) | 491.4 (237.4–2771.8) | 524.1 (116.1–2587.8) | 795.8 (355.2–1961) | 0.479 |
| Unadjusted | Adjusted | |||
|---|---|---|---|---|
| Risk Factors | OR (95% CI) | p | OR (95% CI) | p |
| Systemic immune-inflammation index (SII) | 1.001 (1.0001–1.002) | 0.042 | ||
| Uric acid | 1.44 (1.13–1.84) | 0.003 | 1.41 (1.04–1.93) | 0.028 |
| CRP | 1.34 (1.09–1.65) | 0.005 | 1.27 (1.02–1.58) | 0.033 |
| CRP albumin ratio (CAR) | 3.96 (1.53–10.23) | 0.005 | 3.36 (1.18–7.61) | 0.023 |
| Level of education (high school or university vs. primary or secondary) | 0.1 (0.04–0.25) | <0.001 | 0.05 (0.01–0.18) | <0.001 |
| Marital status (married vs. single or widowed) | 0.22 (0.1–0.48) | <0.001 | 0.17 (0.06–0.52) | 0.002 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Afşar Karatepe, B.; Tasci, G. Inflammatory and Metabolic Blood Parameters Associated with Aggression, Impulsivity, and Suicide Risk Among Male Patients with Antisocial Personality Disorder in a Forensic Psychiatry Unit in Turkey: A Cross-Sectional Comparative Study. Diagnostics 2026, 16, 831. https://doi.org/10.3390/diagnostics16060831
Afşar Karatepe B, Tasci G. Inflammatory and Metabolic Blood Parameters Associated with Aggression, Impulsivity, and Suicide Risk Among Male Patients with Antisocial Personality Disorder in a Forensic Psychiatry Unit in Turkey: A Cross-Sectional Comparative Study. Diagnostics. 2026; 16(6):831. https://doi.org/10.3390/diagnostics16060831
Chicago/Turabian StyleAfşar Karatepe, Berçem, and Gülay Tasci. 2026. "Inflammatory and Metabolic Blood Parameters Associated with Aggression, Impulsivity, and Suicide Risk Among Male Patients with Antisocial Personality Disorder in a Forensic Psychiatry Unit in Turkey: A Cross-Sectional Comparative Study" Diagnostics 16, no. 6: 831. https://doi.org/10.3390/diagnostics16060831
APA StyleAfşar Karatepe, B., & Tasci, G. (2026). Inflammatory and Metabolic Blood Parameters Associated with Aggression, Impulsivity, and Suicide Risk Among Male Patients with Antisocial Personality Disorder in a Forensic Psychiatry Unit in Turkey: A Cross-Sectional Comparative Study. Diagnostics, 16(6), 831. https://doi.org/10.3390/diagnostics16060831

